The present disclosure relates generally to medical devices for treating an embolus or blood clot in a blood vessel.
One common way for a blood vessel to become obstructed is from deposition of clot inside the lumen of the blood vessels. A clot is understood throughout this application as a product of a blood coagulation in hemostasis. Clots can restrict the antegrade blood flow through the lumens of these blood vessels to the body tissues. To that end, any blockage or obstruction of a blood vessel can lead to many serious medical complications. For example, tissue may become damaged due to the decrease in the oxygen that often results from the obstructions in the vessel. Similarly, brain circulation can be affected and result in an ischemic stroke.
In order to restore flow restoration, the clot needs to be removed from the vasculature. Current clot retrieval devices on the market are constructed of a single tube that acts to retrieve a blood clot by enrapturing the clot through the struts of the stent. Such devices then drag the blood clot through the vasculature and out of the body.
Unfortunately, such approaches can only capture clots from a single tube or catheter and/or from a single side that in turn rely upon the outward force of the stent, and the ability of the struts to latch onto and entrap the clot. The problem with these types of retrievers is that they entrap the clot from the inside of the clot, and not from the outside. Capturing the clot from the inside can present difficulties for several reasons. Most notably, as the clot adheres to the vessel wall, the single-tube device may not have enough force to grasp the clot off of its wall.
Other known approaches have suffered from using fixed basket shapes or delivering baskets to a region of interest in the vasculature unsafely, such as U.S. Pat. Pub. 2015/0265299A1 to the University of Toledo or U.S. Pat. No. 9,358,022 to Inoha LLC. For example, these disclosures deliver a first fixed basket proximally relative to the clot and then deliver a second fixed basket distal of the clot. During positioning of the second fixed basket, however, these approaches tend to puncture the clot and risk injury to the patient by permitting particles dislodged from the clot to enter the flow of blood in the vasculature.
Previously known solutions have therefore depended on factors such as material, size, cell design, pre-determined basket size, unsafe deliveries, and internal friction of the clot retrievers. Previous approaches have also focused heavily on extra manipulation by the end-user to precisely, safely, and reliably arrange and position the clot capturing devices within the vasculature without rupturing the vessel wall or allow particles of the clot to enter the flow of blood in the vasculature. In turn, success and safety has relied heavily on end-user accuracy during delivery. Such approaches therefore unnecessarily increase risk of injury to the patient. Moreover, such clot capturing devices can be difficult to recapture after being delivered and/or deployed to vasculature areas of interest further risking detrimental effects of brain and/or cardiac function, including fatality, can result.
Therefore, prior approaches for removal of such clots have suffered from being too intrusive, unsafe, lack control and exert too much pressure on the vessel itself. Accordingly, there remains a need for new devices to safely and effectively remove an obstructing clot within the blood vessel wall.
In some aspects, the present disclosure relates to a multi-basket clot capturing device that includes a distal basket connected to a wire. The distal basket may be operable to capture a distal portion of a clot. A proximal basket may be connected to a hypotube that is slidably axially connected to the wire. The proximal basket may be operable to capture a proximal portion of the clot. A cage can form between the proximal and distal baskets around multiple portions of the clot for capturing the clot. Moving from collapsed to expanded states may be accomplished by moving the microcatheter proximally relative to the clot or by moving the guide wire or hypotube distally relative to the clot.
In some examples, the cage forms around at least two portions of the clot that are opposed. The distal and/or proximal baskets can include a closed end opposite an open end. A frame of the respective basket may be defined between the closed and open end thereby forming a chamber or void operable to capture a portion of the clot (e.g. the distal portion or proximal portion of the clot). The frame may also be adjustable between a plurality of sizes or be constructed from material that conforms to the size and shape of the clot.
A microcatheter may be included with the multi-basket clot capturing device, the microcatheter being deliverable to a region of interest in the vasculature. In this regard, the hypotube and the wire may be slidably axially within the microcatheter. Moving the wire distally away from the microcatheter can cause the distal basket to move from a collapsed state to an expanded state so the frame of the distal basket is capable of capturing a distal portion of the clot. In certain embodiments, moving the microcatheter proximally, away from the distal basket, can cause the proximal basket to move from a collapsed state to an expanded state whereby the proximal basket is capable of capturing a proximal portion of the clot opposite the distal portion of the clot.
In certain examples, a plurality of struts of the distal basket are included that are operable to capture the clot. A plurality of spoke members can be pivotally connected between the struts and a distal end of the hypotube. In this respect, moving the hypotube distally can cause the spoke members to expand the distal basket. A plurality of interstices can be formed from or between the struts. The spoke members may be formed by cutting or etching into the hypotube. The spoke members may also be removably attached to the hypotube. The spoke members may be radially spaced about the hypotube. In certain examples, the hypotube may be axially connected to the proximal basket. The wire may also be axially connected to the distal basket.
In other examples, a method is disclosed for removing a clot from vasculature of a patient. The method may include some or all of the following steps: introducing a multi-basket clot capturing device into a region of interest of the vasculature distal of the clot, the device comprising a distal basket connected to a wire and a proximal basket connected to a hypotube that is axially and slidably connected to the wire, the distal basket being operable to capture a distal portion of the clot; moving the wire connected to the distal basket distal to the clot thereby causing the distal basket to expand away from a microcatheter connected to the wire and hypotube; moving the wire until the distal basket captures the distal portion of the clot; moving the microcatheter proximally causing a proximal basket of the clot capturing device to expand, the proximal basket being operable to capture a proximal portion of the clot; moving the wire connected to the distal basket until contacting a distal end of the hypotube forming a cage around the clot between the proximal and distal baskets.
The method may also include: removing the clot from the region of interest of the vasculature; forming a plurality of interstices on the distal and/or proximal baskets for capturing the clot; pivotally connecting a plurality of spoke members of the hypotube to a plurality of struts of the distal basket; and/or moving the hypotube towards the distal basket away from the microcatheter, while keeping the wire connected to the distal basket in place, thereby causing the distal basket to expand. The method may also include: forming a plurality of interstices from the struts; forming the spoke members by cutting or etching into the distal end of the hypotube; radially spacing the spoke members about the hypotube. The method may also include attaching the spokes to the distal basket by glue, welding, adding a hinge joint between one or more strut of the distal basket and a respective spoke of the hypotube. The method may also include axially connecting the hypotube to a central vertex of the proximal basket; and/or axially connecting the wire to a central vertex of the distal basket.
A method for deploying a basket of a multi-basket clot capturing device is also disclosed. The method can include expanding a frame of a first basket about a first portion of a clot, the frame being slidably axially connected to a hypotube and a wire, the frame being expanded by: sliding outwardly a distal end of the hypotube about the wire when the frame is collapsed and aligned with the hypotube and wire; and radially pivoting a plurality of spokes attached between a distal end of a hypotube and a plurality of struts of the basket.
Other aspects and features of the present disclosure will become apparent to those of ordinary skill in the art, upon reviewing the following detailed description in conjunction with the accompanying figures.
Reference will now be made to the accompanying drawings, which are not necessarily drawn to scale.
Although examples of the disclosed technology are explained in detail herein, it is to be understood that other examples are contemplated. Accordingly, it is not intended that the disclosed technology be limited in its scope to the details of construction and arrangement of components set forth in the following description or illustrated in the drawings. The disclosed technology is capable of other examples and of being practiced or carried out in various ways.
It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. By “comprising” or “containing” or “including” it is meant that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if the other such compounds, material, particles, method steps have the same function as what is named.
In describing examples, terminology will be resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Steps of a method may be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that the mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified.
As discussed herein, vasculature of a “subject” or “patient” may be vasculature of a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like). It should be appreciated that the subject may be any applicable human patient, for example.
As discussed herein, “operator” may include a doctor, surgeon, or any other individual or delivery instrumentation associated delivery of microcatheter(s) and removal of clots from vasculature of a subject.
The herein disclosed clot capturing device 100 resolves known problems in the field by providing a multi-tubed, multi-basket approach that adjustably and safely captures the clot from multiple opposed sides. In certain examples, device 100 is operable to capture a clot that is in a blood vessel from outside of the clot 10, meaning, from opposite sides of the same clot 10. It is understood that device 100 is capable of being used within a blood vessel having diameters ranging between 2 and 5.5 mm approximately. However, the device 100 is not so limited and device 100 may be scaled for use within any vasculature as needed or required.
Baskets 20 and 30 may be axially aligned and connected through a hypotube 40 and wire 50. Hypotube 40 may be slideably inserted over wire 50 though device 100 is not so limited and wire 50 may be slideably inserted over hypotube 40. As described more particularly below, moving hypotube 40 and/or wire 50 may in turn cause corresponding baskets 20 and 30 to move from collapsed states to one or more expanded states. In certain examples, only one expanded state may exist for each basket or one or both baskets 20 and 30 may be adjusted between a plurality of different expanded states according to the size of the clot 10.
As can be seen in
This slidable, pivoting expansion can be best understood with how a conventional umbrella moves from being collapsed to expanded. The distal basket 30 may be axially aligned and attached to wire 50 at its central vertex 35. The distal basket 30 may also be fastened to hypotube 40 (e.g. being threaded thereto) to which the proximal basket 20 is attached on the opposite, proximal portion of hypotube 40 as shown in
Turning to
Each basket 20 and/or 30 can be made of rigid material such as Nitinol and formed (e.g. heat set) to include a cavity, chamber, or void operable to capturing and retaining a blood clot therein (e.g. a basket shape). When assembled, device 100 can be activated between collapsed and deployed states. For example, in a collapsed state one or both basket can be stowed in or along hypotube 40 and wire 50 of device 100. In contrast, in a deployed state, baskets 20 and/or 30 may be moved along hypotube 40 and/or wire 50 to slide therealong and expand until forming its respective void or chamber.
Specifically, hypotube 40 can be attached to the proximal basket 20 and may be cut to create spokes 44 that can be attached to struts 34 of the distal basket 30. The hypotube 40 can be moved (e.g. pushed) relative to a wire 50 that is axially and/or slidably connected therewith as shown particularly in
Turning to
In
Distal basket 30 may be deployed and moved distally from a collapsed state within microcatheter 70 to an expanded stated with its basket chamber ready for capturing a distal portion of clot 10. As previously described, positioning basket 30 distal of clot 10 in this manner without puncturing clot 10 is particularly advantageous as this can provide an added level of safety. Whereas prior approaches have punctured or otherwise contacted clot 10 during removal, this distal deployment of basket 30 prevents any particles from being dislodged from clot 10 during delivery and entering the bloodstream. The only puncturing, if any, would be caused by the initial microcatheter 70 puncturing the clot 10. Basket 30 may be deployed to the expanded stated by moving and/or sliding forward wire 50 relative to hypotube 40 to cause spokes 44 to pivot outwards the frame of basket 30. It is understood that any other mode of expansion can be used to move basket 30 from its collapsed to expanded states and/or multiple settings of basket 30's frame may be used for varying sized basket chambers or voids to correspond to similarly sized clots. Once deployed from the microcatheter 70, the distal basket 30 can be seen distal of the clot ready to adhere, contact, capture, or otherwise communicate with the distal portion of clot 10. In certain examples, the distal basket 30 can be expanded and/or collapsed completely or partially back into the microcatheter 70.
In
In
In certain embodiments, adjusting the size of basket 30 can be achieved by the operator or physician controlling the hypotube 40 and/or wire 50 relative to the other. For example, the hypotube 40 and/or wire 50 may have a plurality of predefined notches or positions associated with respective volumes of basket 30 and/or 20. In this respect, the operator can move an alignment mechanism between respective notches or positions of hypotube 40 and/or wire 50 to easily and precisely adjust the volume of a respective basket.
As seen in
This can be more clearly seen in
Each notch 77 may be separated a distance and aligned to receive corresponding notch 87 of member 82. In certain embodiments, handle 80 includes a series of notches 87 corresponding to predetermined sizes of basket 30. For example, sliding 82 between a first notch and a second notch may cause corresponding basket 30 to expand from a first volume to a second volume. The solution of device 100 is not limited to the foregoing approaches to adjustment and other modes of adjustment are also contemplated for use with device 100 as needed or required.
Turning to
The specific configurations, choice of materials and the size and shape of various elements can be varied according to particular design specifications or constraints requiring a system or method constructed according to the principles of the disclosed technology. Such changes are intended to be embraced within the scope of the disclosed technology. The presently disclosed examples, therefore, are considered in all respects to be illustrative and not restrictive. It will therefore be apparent from the foregoing that while particular forms of the disclosure have been illustrated and described, various modifications can be made without departing from the spirit and scope of the disclosure and all changes that come within the meaning and range of equivalents thereof are intended to be embraced therein.
The present application is a continuation application of U.S. patent application Ser. No. 15/334,984 filed Oct. 26, 2016. The entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
6066149 | Samson et al. | May 2000 | A |
6210370 | Chi-Sing et al. | Apr 2001 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6485502 | Don Michael et al. | Nov 2002 | B2 |
7214237 | Don Michael et al. | May 2007 | B2 |
8088140 | Ferrera et al. | Jan 2012 | B2 |
8945172 | Ferrera et al. | Feb 2015 | B2 |
9232992 | Heidner | Jan 2016 | B2 |
9351749 | Brady et al. | May 2016 | B2 |
9358022 | Morsi | Jun 2016 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9743944 | Bonneau et al. | Aug 2017 | B1 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9833252 | Sepetka | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
20020062135 | Mazzocchi et al. | May 2002 | A1 |
20020072764 | Sepetka | Jun 2002 | A1 |
20050038447 | Huffmaster | Feb 2005 | A1 |
20060015136 | Besselink | Jan 2006 | A1 |
20060064151 | Guterman | Mar 2006 | A1 |
20070078481 | Magnuson | Apr 2007 | A1 |
20080281350 | Sepetka | Nov 2008 | A1 |
20100268265 | Krolik et al. | Oct 2010 | A1 |
20100324649 | Mattsson | Dec 2010 | A1 |
20110202088 | Eckhouse | Aug 2011 | A1 |
20110213403 | Aboytes | Sep 2011 | A1 |
20120116443 | Ferrera et al. | May 2012 | A1 |
20120283768 | Cox et al. | Nov 2012 | A1 |
20130184739 | Brady et al. | Jul 2013 | A1 |
20130197567 | Brady et al. | Aug 2013 | A1 |
20130345739 | Brady et al. | Dec 2013 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140142598 | Fulton, III | May 2014 | A1 |
20140200607 | Sepetka et al. | Jul 2014 | A1 |
20140200608 | Brady et al. | Jul 2014 | A1 |
20140249565 | Laine | Sep 2014 | A1 |
20140316428 | Golan | Oct 2014 | A1 |
20150196744 | Aboytes | Jul 2015 | A1 |
20150223829 | Aboytes | Aug 2015 | A1 |
20150265299 | Cooper et al. | Sep 2015 | A1 |
20160192953 | Brady et al. | Jul 2016 | A1 |
20160192954 | Brady et al. | Jul 2016 | A1 |
20160192955 | Brady et al. | Jul 2016 | A1 |
20160192956 | Brady et al. | Jul 2016 | A1 |
20160206344 | Bruzzi et al. | Jul 2016 | A1 |
20160354098 | Martin et al. | Dec 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Granfield | Apr 2017 | A1 |
20170100183 | Iaizzo et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
Number | Date | Country |
---|---|---|
104159525 | Nov 2014 | CN |
104768479 | Jul 2015 | CN |
105208950 | Dec 2015 | CN |
1 452 142 | Aug 2004 | EP |
2001-522639 | Nov 2001 | JP |
2009-509719 | Mar 2009 | JP |
2010102307 | Sep 2010 | WO |
2014055609 | Apr 2014 | WO |
Entry |
---|
Extended European Search Report dated Jan. 23, 2018 during the prosecution of European Patent Application No. 17198329.9 (parent U.S. Appl. No. 15/334,984). |
Chinese Search Report issued in Chinese Application No. 201711020378.8 dated Nov. 20, 2021, English translation only. |
Number | Date | Country | |
---|---|---|---|
20200100887 A1 | Apr 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15334984 | Oct 2016 | US |
Child | 16702034 | US |